On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...